Hot Products
| Catalog No. | Information |
| CFN60262 | Letrozole |
| CFN89166 | Leucosceptoside A Leucosceptoside A shows inhibitory activity against PKCalpha with the IC50 value of 19.0 microM; it also exhibits strong inhibitory capacity against α-glucosidase. Leucosceptoside A has antihypertensive effect, it shows angiotensin converting enzyme (ACE) inhibitory effect in a dose-dependent manner of which IC(50) value of 423+/-18.8 microg/ml. |
| CFN98333 | Leucoside Pure leucoside can be prepared by enzymatic partial hydrolysis of tea seed extract . |
| CFN99707 | Levistilide A Traditional formula compatibility of Danggui-Shaoyao-San could significantly enhance levistilide A bioavailability compared with levistilide A alone and Rhizoma Chuanxiong. |
| CFN99800 | Levodopa Levodopa is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), used to treat Parkinson's symptoms. |
| CFN93108 | L-Glutamic acid L-Glutamic acid is probably an excitatory transmitter of major significance in the mammalian central nervous system. L-Glutamic acid and L-lysine as useful building blocks for the preparation of bifunctional DTPA-like ligands. |
| CFN70149 | L-Glutamine L-Glutamine prevents acetaldehyde-induced disruption of the tight junction and increase in the paracellular permeability in Caco-2 cell monolayer by an EGF receptor-dependent mechanism. It prevents oxidant- or endotoxin-induced death of neonatal enterocytes. |
| CFN91725 | L-Histidine L-Histidine is an essential amino acid for infants. L-Histidine is an inhibitor of mitochondrial glutamine transport.L-Histidine is also required for blood cell manufacture and protects tissues against damage caused by radiation and heavy metals. IC50 & Target: Microbial Metabolite; Human Endogenous Metabolite |
| CFN91727 | L-Hydroxyproline L-Hydroxyproline, one of the hydroxyproline (Hyp) isomers, is a useful chiral building block in the production of many pharmaceuticals. IC50 & Target: Human Endogenous Metabolite |
| CFN98244 | Licarin A Licarin A and (-)-Licarin A are promising compounds that could be used for the development of schistosomicidal and trypanocidal agents; Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro; (-)-Licarin A has antimycobacterial activity, represents a potentially active anti-tuberculosis agent to treat MDR M. tuberculosis and NTM strains.Licarin A significantly protects primary cultured neuronal cells against glutamate-induced oxidative stress, via antioxidative activities. |
